Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1998 per EA under NDC 43547005103. Its NADAC has been published 191 times since Mar 29, 2023.

FDA first approved this application on Aug 11, 2022. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

tadalafil
$0.1998per EA

Strength

20 mg/1

NDC

43547005103

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210609

FDA Approved

8/11/2022

TE Code

AB1

On Market Since

1/18/2022

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 191 times since Mar 29, 2023, and over the history we have for it it has declined 40.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1998 per EA
All-time high$0.3473 (May 10, 2023)
All-time low$0.1568 (Nov 20, 2024)
52-week high$0.2101
52-week low$0.1582
Median price$0.2137
Average price$0.2309
Largest weekly change-43.5% (Nov 20, 2024)
Weeks tracked191
Tracking sinceMar 29, 2023

Price History

1W

+5.9%

1M

+19.6%

3M

+26.3%

6M

+11.2%

1Y

-4.9%

3Y

-26.9%

5Y

N/A

All

-40.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1998 per EA (NDC 43547005103), effective Nov 18, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 40.5%. It has been tracked across 191 weekly CMS publications since Mar 29, 2023.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since Mar 29, 2023, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1568 (Nov 20, 2024) to a high of $0.3473 (May 10, 2023), with a median of $0.2137 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 20 MG TABLET, is $0.1439 per EA — about 28% below TADALAFIL 20 MG TABLET.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 43547005103) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.